Products

UpDoc Inc.
UpDoc Inc.
Clinical Decision Support & Reference
UpDoc is an FDA-cleared, enterprise-ready agentic clinical AI platform that integrates with EHRs to deploy AI agents for continuous, physician-governed care-related tasks, especially for chronic disease management.
UpDoc
UpDoc
Clinical Decision Support & Reference
UpDoc is an FDA-cleared AI platform that delivers physician-level care and continuous, evidence-based clinical interventions for chronic disease management between patient visits.

See all 2 products →

About UpDoc

UpDoc is a physician-led, AI-enabled clinical AI company that is pioneering a new care delivery paradigm focused on Remote Patient Intervention (RPI). Their platform combines automated agentic AI with clinician oversight to deliver proactive, evidence-based care at scale, particularly for chronic disease management. UpDoc’s system is designed to extend the reach of physicians by enabling continuous, high-touch care between scheduled visits, which traditionally has been a significant gap in chronic disease management.

For physicians, UpDoc’s platform integrates seamlessly into existing EHR workflows and allows for the deployment of FDA-cleared AI agents to perform clinical actions autonomously on their behalf, within physician-approved parameters. This includes tasks such as adjusting medications (e.g., insulin titration for Type 2 diabetes), facilitating lab orders, and coordinating with care teams, with all interventions documented in the EHR. The goal is to empower providers to deliver personalized care for every patient without being limited by appointment wait times or administrative burdens, ultimately aiming to improve patient outcomes, reduce healthcare costs, and alleviate clinician burnout.

Focus Areas

AI-driven remote patient intervention chronic disease management medication management clinical AI physician-assisted clinical decision-making EHR integration

Business Intelligence

TechnologyCloud-native, proprietary clinical intelligence platform, large language models (LLMs) optimized for clinical accuracy and patient engagement, Microsoft Azure, Google Cloud's MedLM and Vertex AI

What Physicians Need to Know

AI-Driven Remote Patient Intervention (RPI)
UpDoc pioneers Remote Patient Intervention (RPI), where AI acts on Remote Patient Monitoring (RPM) data to deliver continuous, evidence-based clinical care between scheduled visits. This moves beyond passive monitoring to active intervention.
Chronic Disease Management
The platform specializes in managing chronic diseases at scale, enabling proactive, high-touch care for conditions like Type 2 diabetes, with potential for expansion into cardiology, oncology supportive care, and behavioral health.
Medication Management
UpDoc's AI assistant is designed to manage medication prescriptions and chronic conditions, including initiating insulin titrations and triggering follow-up tests within physician-approved parameters.
Physician-Assisted Clinical Decision-Making
The platform combines automated agentic AI with clinician oversight, allowing licensed clinicians to deploy AI agents that extend clinical reach and deliver physician-level interventions.
EHR Integration
UpDoc's enterprise-ready platform is built for seamless integration into existing EHR environments and clinical workflows, documenting interventions directly in the EHR.
FDA-Cleared Clinical AI
UpDoc has received FDA clearance for its clinical AI platform, making it the first Software as a Medical Device (SaMD) built on patient-facing large language models.
Clinically Validated
The platform's approach was validated through a landmark clinical trial at Stanford Medicine, demonstrating significant improvements in diabetes control and medication adherence compared to standard care.
Physician Tip

UpDoc's platform is designed to amplify physician impact by extending clinical reach and providing continuous, high-touch care between visits, without increasing administrative burden. It empowers physicians to deliver proactive, personalized care at scale, focusing on high-value clinical decision-making. The system is physician-governed, ensuring every clinical action aligns with the patient's treatment plan and maintains accountability.

UpDoc is built for enterprise health systems and integrates directly with Electronic Health Record (EHR) systems and remote patient monitoring devices. They collaborate with major technology providers like Microsoft (leveraging GPT-4 through Azure OpenAI Service) and Google Cloud (leveraging MedLM and fine-tuned models through Vertex AI).

Products by UpDoc

2 products in the directory

UpDoc Inc.
UpDoc Inc.
Clinical Decision Support & Reference
UpDoc is an FDA-cleared, enterprise-ready agentic clinical AI platform that integrates with EHRs to deploy AI agents for continuous, physician-governed care-related tasks, especially for chronic disease management.
UpDoc
UpDoc
Clinical Decision Support & Reference
UpDoc is an FDA-cleared AI platform that delivers physician-level care and continuous, evidence-based clinical interventions for chronic disease management between patient visits.

What the Web Says

UpDoc (updoc.ai) is a telehealth platform that connects users with Australian Health Practitioners for services like medical certificates, prescriptions, and referrals. It has also received FDA clearance for a patient-facing AI application for diabetes management. Reviews are mixed, with many praising its convenience and efficiency, while others express significant frustration with billing, subscription management, and customer support.

Overall: Mixed

Strengths

  • Convenience and accessibility for telehealth services from home.
  • Quick and efficient medical responses and service delivery.
  • User-friendly platform and application.
  • Professional and empathetic practitioners.
  • Ability to obtain medical certificates and scripts quickly.
  • FDA clearance for an AI-powered diabetes management app.

Limitations

  • Issues with billing clarity, unexpected subscription enrollments, and difficulty canceling subscriptions.
  • Difficulties reaching responsive human customer support, often receiving automated or delayed responses.
  • Reports of unauthorized charges and refusal to issue refunds.
  • Concerns about the legitimacy and predatory practices from healthcare professionals on Reddit.
  • Experiences of long wait times for consultations or scripts that never arrived.
  • Unreliable service, increasing costs, and shady cancellation fees for the Updox software (distinct from UpDoc.ai).

Based on reviews from: ProductReview.com.au, Reddit, Apple App Store, Updoc: Online Doctor & Telehealth Consultations Australia (updoc.com.au), Capterra, G2, Trustpilot, MarketScale, 7wire Ventures, Fierce Healthcare

Last updated: 2026-09-28

Videos

News, demos, and interviews about UpDoc.

Loading videos...

Videos load interactively. If none appear, search YouTube for UpDoc →

View all on YouTube

Press & Coverage

unknown
UpDoc Debuts First FDA-Cleared Patient-Facing Clinical LLM for Insulin Management
UpDoc has introduced the first FDA-cleared agentic clinical AI platform with patient-facing large language models, marking a significant regulatory milestone for healthcare AI. The platform, UpDoc V1.0, is a prescription software medical device for insulin management in adults with type 2 diabetes.
2026-07
Dealroom
UpDoc debuts first FDA-cleared clinical AI platform, closes $18M seed round
UpDoc, a Palo Alto startup, received FDA clearance for its Software as a Medical Device built on patient-facing large language models and secured an oversubscribed $18 million seed round. The platform is designed to support doctors by embedding into provider workflows and integrating with electronic health records.
2026-06
Second Opinion Media
Updoc's FDA Win Raises the Stakes for Health AI Rivals
UpDoc's FDA authorization for its AI to adjust insulin doses for Type 2 diabetes patients is a significant development, as many other companies in the health AI space are actively avoiding FDA regulation. Cleveland Clinic will be piloting the program to evaluate its impact on patient outcomes.
2026-06
unknown
UpDoc Wins $9.2M ARPA-H Backing for Clinical AI Agents
UpDoc has been selected as a lead performer in ARPA-H's ADVOCATE program, receiving up to $9.2 million to develop agentic AI for cardiovascular care. The company will collaborate with Microsoft, OpenAI, and NVIDIA on a system aimed at managing heart-failure care with clinical safeguards and pursuing FDA authorization.
2026-09
The AI Library | DevThrottle
UpDoc gets first FDA clearance for a patient-facing large language model medical device
UpDoc announced FDA clearance for what it describes as the first Software as a Medical Device (SaMD) utilizing patient-facing large language models. This platform allows clinicians to deploy AI agents for autonomous clinical tasks like medication adjustments and lab ordering, integrating with electronic health records.
2026-06
Innolitics
First FDA-Cleared AI Agent and LLM Enabled Device Confirmed
UpDoc announced the first FDA-cleared clinical AI platform for real-time patient care, utilizing patient-facing large language models, with $18 million in seed financing and initial deployments at major health systems. The FDA's public 510(k) database shows clearance for UpDoc V1.0, a prescription software medical device for insulin management in adults with type 2 diabetes.
2026-06
PR Newswire
ARPA-H Selects UpDoc to Lead Development of Autonomous Clinical AI System, in an Initiative Joined by Microsoft, OpenAI and NVIDIA
UpDoc has been selected by ARPA-H to lead the ADVOCATE program, receiving an award of up to $9.2 million to develop an autonomous clinical AI system for cardiovascular care, with support from Microsoft, OpenAI, and NVIDIA. This initiative aims to address the urgent need for proactive and scalable approaches to cardiovascular disease prevention and care.
2026-09
American Diabetes Association
The American Diabetes Association's Innovation Fund Invests in UpDoc to Accelerate the Future of AI-Driven Chronic Disease Management and Prevention
The American Diabetes Association (ADA) has made a strategic investment in UpDoc through its Innovation Fund, aiming to accelerate the deployment of UpDoc's patient-facing AI agents for chronic disease management. This investment validates UpDoc's evidence-based approach and supports its mission to deliver clinical-grade, AI-powered interventions to individuals with diabetes and related conditions.
2026-06

Frequently Asked Questions

UpDoc's platform utilizes AI to analyze patient data, identify individuals at risk, and personalize intervention strategies for chronic conditions. This enables proactive care, improved patient engagement, and more efficient management of chronic diseases outside of traditional office visits.
UpDoc offers modules for medication adherence tracking, AI-powered drug interaction alerts, and personalized dosage recommendations. Our clinical AI tools provide evidence-based insights and decision support at the point of care, assisting physicians in optimizing treatment plans.
UpDoc has extensive experience integrating with major EHR systems through standard APIs and custom solutions. Our integration process involves a thorough assessment of your current infrastructure, followed by a phased implementation and rigorous testing to ensure seamless data flow and minimal disruption.
UpDoc is fully HIPAA compliant, employing robust encryption, access controls, and regular security audits to protect patient data. Our platform is designed with privacy by design principles, ensuring all data handling adheres to the highest industry standards and regulatory requirements.
UpDoc offers flexible pricing models tailored to the size and needs of your practice, including subscription tiers based on features and patient volume. We also offer per-patient fees for certain services, and our sales team can provide a detailed quote after understanding your specific requirements.
UpDoc provides comprehensive support, including dedicated account managers, 24/7 technical assistance, and ongoing training for your staff. We also offer regular performance reviews and optimization consultations to ensure you're maximizing the value of our platform.
Yes, UpDoc has strategic partnerships with leading healthcare technology providers and academic institutions to enhance our platform's capabilities and expand our reach. These collaborations focus on areas like advanced analytics, telehealth, and research to bring the best solutions to our clients.
UpDoc is a well-funded and rapidly growing company with a clear long-term vision for transforming healthcare through AI. Our commitment to continuous innovation, strong financial backing, and a dedicated team ensures we will remain a stable and supportive partner for years to come.

Investors

Who's funded UpDoc.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

TimeDoc Health is a healthcare technology and services company that provides virtual care management solutions, primarily focusing on chronic care management (CCM), remote patient monitoring (RPM), and behavioral health integration (BHI). Their platform and services are designed to help healthcare organizations, including primary care providers, health systems, FQHCs (Federally Qualified Health Centers), and Medicare Advantage […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.